Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Generic immunosuppressants: the European perspective.

Christians U.

Transplant Proc. 1999 May;31(3A Suppl):19S-22S. Review. No abstract available.

PMID:
10330954
2.

Can generics be trusted?

Pondrom S.

Am J Transplant. 2010 Apr;10(4):708-9. doi: 10.1111/j.1600-6143.2009.03058.x. No abstract available.

3.

Generic immunosuppressant use in solid organ transplantation.

Alloway RR.

Transplant Proc. 1999 May;31(3A Suppl):2S-5S. Review.

PMID:
10330948
4.

Generic cyclosporine formulations: more open questions than answers.

Cattaneo D, Perico N, Remuzzi G.

Transpl Int. 2005 Apr;18(4):371-8. Review.

5.

Generic immunosuppression in transplantation: current evidence and controversial issues.

El Hajj S, Kim M, Phillips K, Gabardi S.

Expert Rev Clin Immunol. 2015 May;11(5):659-72. doi: 10.1586/1744666X.2015.1026895. Epub 2015 Mar 30. Review.

PMID:
25817258
6.

Generic immunosuppressants in hematopoietic cell transplantation.

Cutler C, Kesselheim A, Gabardi S, Andersson BS, Carpenter P, Khoury HJ, Litzow M, Rowley SD, Lanum S, Leather H, Tina Shih YC, Gale RP, Wingard JR, Appelbaum FR, Anasetti C; American Society of Blood and Marrow Transplantation.

Biol Blood Marrow Transplant. 2011 Mar;17(3):285-90. doi: 10.1016/j.bbmt.2010.11.006. Epub 2010 Nov 16. No abstract available.

7.

Problems with the automatic switching of generic cyclosporine oral solution for the innovator product.

Haug M 3rd, Wimberley SL.

Am J Health Syst Pharm. 2000 Jul 15;57(14):1349-53. No abstract available.

PMID:
10918926
8.

Generic drugs: the Canadian perspective.

McGilveray IJ, Gallicano K.

Transplant Proc. 1999 May;31(3A Suppl):16S-18S. Review. No abstract available.

PMID:
10330953
9.

Scientific and professional concerns regarding product interchange and subsequent monitoring of cyclosporine and other critical dose drugs.

Barr WH.

Transplant Proc. 1999 May;31(3):1645-8; discussion 1675-84. Review. No abstract available.

PMID:
10331033
10.

Safety and efficacy of generic cyclosporine arpimune in Filipino low-risk primary kidney transplant recipients.

Pamugas GE, Danguilan RA, Lamban AB, Mangati VB, Ona ET.

Transplant Proc. 2012 Jan;44(1):101-8. doi: 10.1016/j.transproceed.2011.12.002.

PMID:
22310590
11.

Recommendations concerning the introduction of generic formulations of cyclosporine.

Kahan BD.

Transplant Proc. 1999 May;31(3):1634; discussion 1675-84. No abstract available.

PMID:
10331030
12.

[Improved immunosuppression leads to better kidney transplantations].

Ekberg H.

Lakartidningen. 2012 Sep 26-Oct 9;109(39-40):1739-42. Review. Swedish. No abstract available.

PMID:
23097879
13.

Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory.

Uber PA, Ross HJ, Zuckermann AO, Sweet SC, Corris PA, McNeil K, Mehra MR.

J Heart Lung Transplant. 2009 Jul;28(7):655-60. doi: 10.1016/j.healun.2009.05.001. Epub 2009 Jun 3. Review. No abstract available.

PMID:
19560691
14.

Considerations concerning generic formulations of immunosuppressive drugs.

Kahan BD.

Transplant Proc. 1999 May;31(3):1635-41. No abstract available.

PMID:
10331031
15.

Report of the American Society of Transplantation conference on immunosuppressive drugs and the use of generic immunosuppressants.

Alloway RR, Isaacs R, Lake K, Hoyer P, First R, Helderman H, Bunnapradist S, Leichtman A, Bennett MW, Tejani A, Takemoto SK.

Am J Transplant. 2003 Oct;3(10):1211-5.

16.

A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001.

Pollard S, Nashan B, Johnston A, Hoyer P, Belitsky P, Keown P, Helderman H; CONSENT: Consensus on Substitution in European Transplantation.

Clin Ther. 2003 Jun;25(6):1654-69. Review.

PMID:
12860490
17.

Recommendations for bioequivalence testing of cyclosporine generics revisited.

Christians U, First MR, Benet LZ.

Ther Drug Monit. 2000 Jun;22(3):330-45. Review.

PMID:
10850403
18.

Generic substitution for cyclosporine: what should we be looking for in new formulations?

Johnston A, Holt DW.

Transplant Proc. 1998 Aug;30(5):1652-3. Review. No abstract available.

PMID:
9723228
19.

The end of the beginning?

[No authors listed]

Nat Biotechnol. 2006 Apr;24(4):367. No abstract available.

PMID:
16601702
20.

Supplemental Content

Support Center